These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30643454)

  • 1. Polymorphisms in DNA repair pathway genes and
    Hu X; Qin W; Li S; He M; Wang Y; Guan S; Zhao H; Yao W; Wei M; Liu M; Wu H
    Cancer Manag Res; 2019; 11():285-297. PubMed ID: 30643454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
    Sun K; Gong A; Liang P
    Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleotide excision repair pathway gene polymorphisms are associated with risk and prognosis of colorectal cancer.
    Li YK; Xu Q; Sun LP; Gong YH; Jing JJ; Xing CZ; Yuan Y
    World J Gastroenterol; 2020 Jan; 26(3):307-323. PubMed ID: 31988591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population.
    Gao C; Wang J; Li C; Zhang W; Liu G
    PLoS One; 2016; 11(9):e0160801. PubMed ID: 27622501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
    Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
    Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
    Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
    Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of mRNA expression of DNA repair genes and genetic polymorphisms with cancer risk: a bioinformatics analysis and meta-analysis.
    Wu H; Li S; Hu X; Qin W; Wang Y; Sun T; Wu Z; Wang X; Lu S; Xu D; Li Y; Guan S; Zhao H; Yao W; Liu M; Wei M
    J Cancer; 2019; 10(16):3593-3607. PubMed ID: 31333776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
    Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of six polymorphisms of five genes involved in three steps of nucleotide excision repair pathways with hepatocellular cancer risk.
    Wang B; Xu Q; Yang HW; Sun LP; Yuan Y
    Oncotarget; 2016 Apr; 7(15):20357-67. PubMed ID: 26967386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of XRCC1 gene polymorphism on the prognosis and safety of stage Ⅲ patients with colorectal cancer who received oxaliplatin based adjuvant chemotherapy].
    Li RX; Shang JH; Sun JF
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):759-765. PubMed ID: 33765714
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional polymorphisms of the lncRNA
    Qin W; Wang X; Wang Y; Li Y; Chen Q; Hu X; Wu Z; Zhao P; Li S; Zhao H; Yao W; Ding J; Wei M; Wu H
    Cancer Cell Int; 2019; 19():215. PubMed ID: 31452627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Significant Increasing Risk Association between Cigarette Smoking and
    Almushawwah S; Almutairi MH; Alamri AM; Semlali A
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of single-nucleotide polymorphisms in DNA repair pathway genes on response to chemoradiotherapy in rectal cancer patients: Results from ACCORD-12/PRODIGE-2 phase III trial.
    Boige V; Mollevi C; Gourgou S; Azria D; Seitz JF; Vincent M; Bigot L; Juzyna B; Miran I; Gerard JP; Laurent-Puig P
    Int J Cancer; 2019 Dec; 145(11):3163-3172. PubMed ID: 31107542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetic predictors of severe peripheral neuropathy in colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy: a GEMCAD group study.
    Custodio A; Moreno-Rubio J; Aparicio J; Gallego-Plazas J; Yaya R; Maurel J; Higuera O; Burgos E; Ramos D; Calatrava A; Andrada E; López R; Moreno V; Madero R; Cejas P; Feliu J
    Ann Oncol; 2014 Feb; 25(2):398-403. PubMed ID: 24351404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
    Lin WR; Chiang JM; Liang KH; Lim SN; Lai MW; Tsou YK; Hsieh TY; Hsu CK; Yeh CT
    Medicine (Baltimore); 2016 Apr; 95(17):e3487. PubMed ID: 27124048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer.
    Stoehlmacher J; Park DJ; Zhang W; Yang D; Groshen S; Zahedy S; Lenz HJ
    Br J Cancer; 2004 Jul; 91(2):344-54. PubMed ID: 15213713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of single nucleotide polymorphisms in MTHFR and ABCG2 with the different efficacy of first-line chemotherapy in metastatic colorectal cancer.
    Zhao J; Li W; Zhu D; Yu Q; Zhang Z; Sun M; Cai S; Zhang W
    Med Oncol; 2014 Jan; 31(1):802. PubMed ID: 24338217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in DNA repair genes of XRCC1, XPA, XPC, XPD and associations with lung cancer risk in Chinese people.
    Mei C; Hou M; Guo S; Hua F; Zheng D; Xu F; Jiang Y; Li L; Qiao Y; Fan Y; Zhou Q
    Thorac Cancer; 2014 May; 5(3):232-42. PubMed ID: 26767006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risks.
    Liu J; Sun L; Xu Q; Tu H; He C; Xing C; Yuan Y
    Oncotarget; 2016 Feb; 7(6):6972-83. PubMed ID: 26760766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.
    Park JH; Kim NS; Park JY; Chae YS; Kim JG; Sohn SK; Moon JH; Kang BW; Ryoo HM; Bae SH; Choi GS; Jun SH
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1135-42. PubMed ID: 20091185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.